Vivimed Labs Ltd
₹6.26
(3.84%)
Sat, 30 May 2026, 03:28 pm
Vivimed Labs Share Price Live Chart
1 Day
(3.84%)
No Result Found
Summary
Market Cap
54.81
Net Profit
-31.96
P/B
0
Sector P/E
34.30
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.04
RONW (Industry)
13.17
ROE
0
ROCE
0
Debt/Equity
0
EPS (TTM)
0
Dividend Yield
0
Book Value
-10.37
Interest Cover
-9.69
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 7.57 | 7.77 | 7.77 | 7.77 | 20.94 |
| FII | 1.64 | 1.64 | 1.64 | 1.64 | 1.64 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 90.67 | 90.48 | 90.48 | 90.48 | 77.30 |
| Government | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 12.58 | 9.63 | 8.20 | 6.68 | 5.25 | 3.73 | 0.78 |
| Fibonacci | 9.63 | 8.50 | 7.80 | 6.68 | 5.55 | 4.85 | 3.73 |
| Camarilla | 7.59 | 7.32 | 7.05 | 6.68 | 6.51 | 6.24 | 5.97 |
Pivots Level: Classic
R3
+5.90
12.58
R2
+2.95
9.63
R1
+1.53
8.20
S1
-1.42
5.25
S2
-2.95
3.73
S3
-5.90
0.78
Moving Average
Period
Value
10-EMA
6.55
20-EMA
6.61
30-EMA
6.67
50-EMA
6.88
100-EMA
7.59
200-EMA
8.90
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 30 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 28 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 13 Mar 2026 | board-meetings | Quarterly Results | |
| 13 Feb 2026 | board-meetings | Quarterly Results | |
| 17 Nov 2025 | egm | ||
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 06 Sept 2025 | agm | ||
| 11 Dec 2024 | agm | ||
| 27 Nov 2024 | agm | Annual General Meeting | 28 Dec 2024 |
| 05 Jul 2024 | egm |
Peer Comparison
Vivimed Labs Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Vivimed Labs Ltd About
Vivimed Labs is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1988
Headquarters
CEO
V Manohar Rao
Employees
Contact
Website
http://www.vivimedlabs.com
yugandhar.kopparthi@vivimedlabs.com
Phone
91-8482-232045
Location
Plot No 78-A, Kolhar Industrial Area, Bidar, Karnataka, 585403
Vivimed Labs Ltd Company History
| Year | History |
|---|---|
| 2012 |
|
| 2013 |
|
| 2014 |
|
| 2016 |
|
| 2020 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| KRONE FINSTOCK PRIVATE LIMITED | bulk | Sell | 581010 | 7.41 | 10 Feb 2026 |
| KRONE FINSTOCK PRIVATE LIMITED | bulk | Buy | 6010 | 7.68 | 10 Feb 2026 |
| KAMAL JEET GUPTA | bulk | Sell | 130000 | 7.82 | 20 Jan 2026 |
| KAMAL JEET GUPTA | bulk | Buy | 430000 | 8.17 | 20 Jan 2026 |
| NEO APEX VENTURE LLP | bulk | Sell | 298970 | 12.25 | 06 Jan 2026 |
| MERU INVESTMENTS | bulk | Buy | 450000 | 12.25 | 06 Jan 2026 |
| NEO APEX VENTURE LLP | bulk | Buy | 1048963 | 12.25 | 06 Jan 2026 |
| A AND S TRADELINK | bulk | Buy | 712573 | 6.42 | 03 Apr 2023 |
| LUHARUKA MEDIA & INFRA LTD | bulk | Sell | 551627 | 7.66 | 21 Jun 2022 |
| KRONE FINSTOCK PRIVATE LIMITED | bulk | Sell | 431000 | 15.15 | 29 Mar 2022 |